A blurb from Chemical &Engineering News:
"The US government will pay $265 million under its Operation Warp Speed program to reserve capacity for manufacturing COVID-19 vaccines at Fujifilm Diosynth Biotechnologies’ facility in College Station, Texas. The government has a similar agreement with Emergent BioSolutions in Maryland. Fujifilm says some of the capacity will be allocated to the vaccine being developed by Novavax. Fujifilm recently signed a deal to manufacture the Novavax vaccine in Morrisville, North Carolina, for clinical trials before transferring production to Texas. "
"The US government will pay $265 million under its Operation Warp Speed program to reserve capacity for manufacturing COVID-19 vaccines at Fujifilm Diosynth Biotechnologies’ facility in College Station, Texas. The government has a similar agreement with Emergent BioSolutions in Maryland. Fujifilm says some of the capacity will be allocated to the vaccine being developed by Novavax. Fujifilm recently signed a deal to manufacture the Novavax vaccine in Morrisville, North Carolina, for clinical trials before transferring production to Texas. "